What This Lancet Review Really Says About Cannabinoids in Psychiatry
A new Lancet Psychiatry review examined 54 randomized trials of cannabinoids for mental disorders and substance use disorders, and the evidence was thinner than many public claims suggest. A few outcomes showed signals, especially in cannabis use…
Cannabis Use Disorder Heart Attack Study: 7 Crucial Reality Checks
The cannabis use disorder heart attack study highlights increased cardiovascular risk in hospitalized MASH cirrhosis patients. This analysis clarifies that the study measured diagnosis codes, not direct cannabis exposure. Understanding these nuances…
The Canadian Association of Gastroenterology Requires Guidance when Recommending Medical Cannabis
The Canadian Association of Gastroenterology emphasizes the need for guidance on cannabis use gastroenterological disorders. Their statement reviews current evidence on cannabis benefits and harms. Further research is required to clarify its role in…
